GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hainan Shuangcheng Pharmaceuticals Co Ltd (SZSE:002693) » Definitions » Interest Expense

Hainan Shuangcheng Pharmaceuticals Co (SZSE:002693) Interest Expense : ¥-8.8 Mil (TTM As of Jun. 2024)


View and export this data going back to 2012. Start your Free Trial

What is Hainan Shuangcheng Pharmaceuticals Co Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Hainan Shuangcheng Pharmaceuticals Co's interest expense for the three months ended in Jun. 2024 was ¥ -2.3 Mil. Its interest expense for the trailing twelve months (TTM) ended in Jun. 2024 was ¥-8.8 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Hainan Shuangcheng Pharmaceuticals Co's Operating Income for the three months ended in Jun. 2024 was ¥ -7.3 Mil. Hainan Shuangcheng Pharmaceuticals Co's Interest Expense for the three months ended in Jun. 2024 was ¥ -2.3 Mil. Hainan Shuangcheng Pharmaceuticals Co did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Hainan Shuangcheng Pharmaceuticals Co Interest Expense Historical Data

The historical data trend for Hainan Shuangcheng Pharmaceuticals Co's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hainan Shuangcheng Pharmaceuticals Co Interest Expense Chart

Hainan Shuangcheng Pharmaceuticals Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Interest Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -9.83 -10.01 -9.03 -11.19 -9.58

Hainan Shuangcheng Pharmaceuticals Co Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.56 -2.27 -2.21 -2.00 -2.29

Hainan Shuangcheng Pharmaceuticals Co Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-8.8 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hainan Shuangcheng Pharmaceuticals Co  (SZSE:002693) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Hainan Shuangcheng Pharmaceuticals Co's Interest Expense for the three months ended in Jun. 2024 was ¥-2.3 Mil. Its Operating Income for the three months ended in Jun. 2024 was ¥-7.3 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Jun. 2024 was ¥170.0 Mil.

Hainan Shuangcheng Pharmaceuticals Co's Interest Coverage for the quarter that ended in Jun. 2024 is calculated as

Hainan Shuangcheng Pharmaceuticals Co did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Hainan Shuangcheng Pharmaceuticals Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hainan Shuangcheng Pharmaceuticals Co Ltd (SZSE:002693) » Definitions » Interest Expense
Comparable Companies
BJSE:830946 SZSE:300534 SZSE:301331 SZSE:300086 SZSE:002365 SHSE:600513 SHSE:600080 SZSE:002370 SZSE:300584 SZSE:301111 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
N/A
Address
16 Xingguo Road, Xiuying District, Haikou, CHN, 570311
Website
http://www.shuangchengmed.com
Hainan Shuangcheng Pharmaceuticals Co Ltd is engaged in the research, development, and sales of synthesized peptide drugs.
Executives
Yuan Jian Lin Executives
Zhang Wei Executives
Yu Xiao Feng Directors, executives
Wang Xu Guang Executives
Directors, executives
Wang Cheng Dong Directors, executives
Executives
Hu Yi Securities Affairs Representative

Hainan Shuangcheng Pharmaceuticals Co Headlines

No Headlines